Athersys Gets An Efficacy Signal In Phase I Safety Study Of MultiStem In Heart Attack
This article was originally published in The Pink Sheet Daily
Executive Summary
Patients in a Phase I study of the adult stem cell product showed encouraging improvement in cardiac function, a surprise efficacy signal in addition to a clean safety profile.